EM1702J "What a Long, Strange Trip It’s Been: The Everlasting Controversies over PSA Testing" (IM GR-022417)
My purpose is to provide an update on prostate cancer screening. I will begin by discussing the controversies surrounding PSA testing, critically reviewing results of the major screening trials, and highlighting the impact of guidelines on screening practices and cancer incidence. I will then describe several strategies—using decision aids and offering active surveillance—that have the potential to improve prostate cancer screening and treatment decision making and outcomes.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Describe the findings from clinical trials of prostate cancer screening and treatment
- Assess the effect of PSA testing on the epidemiology of prostate cancer in the U.S.
- Describe guideline recommendations regarding prostate cancer screening and treatment
- Explain the rationale for applying shared decision making to cancer screening and treatment decisions
Richard Hoffman, M.D., M.P.H.
Professor of Internal Medicine and Epidemiology
Director, Division of General Internal Medicine
University of Iowa Carver College of Medicine/Iowa City VA Medical Center
Visiting Professor for General Internal Medicine
- 1.00 AMA